HPV-based screening for prevention of invasive cervical cancer

Affiliations

¹ Department of Gynecology and Gynecologic Oncology, Charite University, Berlin, Germany.
² Department of Obstetrics and Gynaecology, Klinikum Wolfsburg, Wolfsburg, Germany.
³ Department of Gynecology and Gynecologic Oncology, Suleyman Demirel University, Isparta 32260, Turkey. Electronic address: evrimmd@yahoo.com.
⁴ Department of Obstetrics and Gynaecology Helsinki University, Helsinki, Finland.

Comment

Achim Schneider et al. Lancet. 2014.

. 2014 Apr 12;383(9925):1294-1295.

doi: 10.1016/S0140-6736(14)60644-9.

¹ Department of Gynecology and Gynecologic Oncology, Charite University, Berlin, Germany.
² Department of Obstetrics and Gynaecology, Klinikum Wolfsburg, Wolfsburg, Germany.
³ Department of Gynecology and Gynecologic Oncology, Suleyman Demirel University, Isparta 32260, Turkey. Electronic address: evrimmd@yahoo.com.
⁴ Department of Obstetrics and Gynaecology Helsinki University, Helsinki, Finland.

No abstract available

Comment in

HPV-based screening for prevention of invasive cervical cancer - Authors' reply.
Ronco G, Meijer CJL, Segnan N, Kitchener H, Giorgi-Rossi P, Peto J, Dillner J. Ronco G, et al. Lancet. 2014 Apr 12;383(9925):1295. doi: 10.1016/S0140-6736(14)60645-0. Lancet. 2014. PMID: 24725577 No abstract available.

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.
Ronco G, Dillner J, Elfström KM, Tunesi S, Snijders PJ, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P, Berkhof J, Peto J, Meijer CJ; International HPV screening working group. Ronco G, et al. Lancet. 2014 Feb 8;383(9916):524-32. doi: 10.1016/S0140-6736(13)62218-7. Epub 2013 Nov 3. Lancet. 2014. PMID: 24192252